These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


261 related items for PubMed ID: 26518541

  • 1. Prognostic value of combined visualization of MR diffusion and perfusion maps in glioblastoma.
    Deike K, Wiestler B, Graf M, Reimer C, Floca RO, Bäumer P, Kickingereder P, Heiland S, Schlemmer HP, Wick W, Bendszus M, Radbruch A.
    J Neurooncol; 2016 Feb; 126(3):463-72. PubMed ID: 26518541
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery.
    Zolal A, Juratli TA, Linn J, Podlesek D, Sitoci Ficici KH, Kitzler HH, Schackert G, Sobottka SB, Rieger B, Krex D.
    J Neurooncol; 2016 May; 127(3):551-7. PubMed ID: 26830088
    [Abstract] [Full Text] [Related]

  • 6. Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.
    Chu HH, Choi SH, Ryoo I, Kim SC, Yeom JA, Shin H, Jung SC, Lee AL, Yoon TJ, Kim TM, Lee SH, Park CK, Kim JH, Sohn CH, Park SH, Kim IH.
    Radiology; 2013 Dec; 269(3):831-40. PubMed ID: 23771912
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Apparent Diffusion Coefficient and Intravoxel Incoherent Motion for Differentiating among Glioblastoma, Metastasis, and Lymphoma Focusing on Diffusion-Related Parameter.
    Shim WH, Kim HS, Choi CG, Kim SJ.
    PLoS One; 2015 Dec; 10(7):e0134761. PubMed ID: 26225937
    [Abstract] [Full Text] [Related]

  • 8. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
    Burth S, Kickingereder P, Eidel O, Tichy D, Bonekamp D, Weberling L, Wick A, Löw S, Hertenstein A, Nowosielski M, Schlemmer HP, Wick W, Bendszus M, Radbruch A.
    Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme.
    Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS.
    J Neurooncol; 2015 May; 123(1):179-88. PubMed ID: 25894597
    [Abstract] [Full Text] [Related]

  • 10. Apparent diffusion coefficient changes predict survival after intra-arterial bevacizumab treatment in recurrent glioblastoma.
    Galla N, Chiang G, Chakraborty S, Singh R, John Tsiouris A, Boockvar J, Kovanlikaya I.
    Neuroradiology; 2017 May; 59(5):499-505. PubMed ID: 28343250
    [Abstract] [Full Text] [Related]

  • 11. Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients.
    Zhang M, Gulotta B, Thomas A, Kaley T, Karimi S, Gavrilovic I, Woo KM, Zhang Z, Arevalo-Perez J, Holodny AI, Rosenblum M, Young RJ.
    Neuro Oncol; 2016 May; 18(5):735-43. PubMed ID: 26538618
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of a high b-value for diffusion weighted imaging of peritumoral regions to differentiate high-grade gliomas and solitary metastases.
    Han C, Huang S, Guo J, Zhuang X, Han H.
    J Magn Reson Imaging; 2015 Jul; 42(1):80-6. PubMed ID: 25223489
    [Abstract] [Full Text] [Related]

  • 16. Semiquantitative perfusion combined with diffusion-weighted MR imaging in pre-operative evaluation of endometrial carcinoma: results in a group of 57 patients.
    Ippolito D, Cadonici A, Bonaffini PA, Minutolo O, Casiraghi A, Perego P, Sironi S.
    Magn Reson Imaging; 2014 Jun; 32(5):464-72. PubMed ID: 24629513
    [Abstract] [Full Text] [Related]

  • 17. Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.
    John F, Bosnyák E, Robinette NL, Amit-Yousif AJ, Barger GR, Shah KD, Michelhaugh SK, Klinger NV, Mittal S, Juhász C.
    Neuro Oncol; 2019 Feb 14; 21(2):264-273. PubMed ID: 30346623
    [Abstract] [Full Text] [Related]

  • 18. Infiltrative patterns of glioblastoma: Identification of tumor progress using apparent diffusion coefficient histograms.
    Lutz K, Wiestler B, Graf M, Bäumer P, Floca R, Schlemmer HP, Heiland S, Wick W, Bendszus M, Radbruch A.
    J Magn Reson Imaging; 2014 May 14; 39(5):1096-103. PubMed ID: 24115401
    [Abstract] [Full Text] [Related]

  • 19. Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma.
    Lee J, Jain R, Khalil K, Griffith B, Bosca R, Rao G, Rao A.
    AJNR Am J Neuroradiol; 2016 Jan 14; 37(1):37-43. PubMed ID: 26471746
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.
    Lee EJ, terBrugge K, Mikulis D, Choi DS, Bae JM, Lee SK, Moon SY.
    AJR Am J Roentgenol; 2011 Jan 14; 196(1):71-6. PubMed ID: 21178049
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.